COMPANY

Immunova Therapeutics

HQ: Los Angeles, CA source · immunovatherapeutics.com ↗ · West Coast

Keywords: From press sources:oncology triple-negative breast cancer

Location: Los Angeles, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 4

Annual award amounts. Total $4.0M.

Jul 28, 2025 NIH award 5R44CA295183-02 FY2025: $998,971 awarded for that fiscal year; activity R44 (SBIR); PI WANG, YICHENG; recipient as written: IMMUNOVA THERAPEUTICS, LLC, MONROVIA, CA. Development of CD4 TCR-engineered T cell source ↗
Sep 20, 2024 NIH award 1R44CA295183-01 FY2024: $1,001,029 awarded for that fiscal year; activity R44 (SBIR); PI WANG, YICHENG; recipient as written: IMMUNOVA THERAPEUTICS, LLC, MONROVIA, CA. Development of CD4 TCR-engineered T ce source ↗
Jul 18, 2023 NIH award 5R44CA275489-02 FY2023: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI WANG, YICHENG; recipient as written: IMMUNOVA THERAPEUTICS, LLC, MONROVIA, CA. Development of a Therapeutic SAPNANO-E source ↗
Jul 8, 2022 NIH award 1R44CA275489-01 FY2022: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI WANG, YICHENG; recipient as written: IMMUNOVA THERAPEUTICS, LLC, MONROVIA, CA. Development of a Therapeutic SAPNANO-E source ↗